These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Structural cerebellar correlates of cognitive functions in spinocerebellar ataxia type 2. Olivito G; Lupo M; Iacobacci C; Clausi S; Romano S; Masciullo M; Molinari M; Cercignani M; Bozzali M; Leggio M J Neurol; 2018 Mar; 265(3):597-606. PubMed ID: 29356974 [TBL] [Abstract][Full Text] [Related]
28. Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy. Tse NY; Chen Y; Irish M; Cordato NJ; Landin-Romero R; Hodges JR; Piguet O; Ahmed RM Brain Commun; 2020; 2(2):fcaa194. PubMed ID: 33381758 [TBL] [Abstract][Full Text] [Related]
29. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism. Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209 [TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879 [TBL] [Abstract][Full Text] [Related]
31. The Effects of Meditation on Grey Matter Atrophy and Neurodegeneration: A Systematic Review. Last N; Tufts E; Auger LE J Alzheimers Dis; 2017; 56(1):275-286. PubMed ID: 27983555 [TBL] [Abstract][Full Text] [Related]
32. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875 [TBL] [Abstract][Full Text] [Related]
34. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175 [TBL] [Abstract][Full Text] [Related]
35. Neuroimaging in aging and neurologic diseases. Risacher SL; Saykin AJ Handb Clin Neurol; 2019; 167():191-227. PubMed ID: 31753134 [TBL] [Abstract][Full Text] [Related]
36. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration. Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692 [TBL] [Abstract][Full Text] [Related]
37. Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes. Gorges M; Maier MN; Rosskopf J; Vintonyak O; Pinkhardt EH; Ludolph AC; Müller HP; Kassubek J J Neurol; 2017 Sep; 264(9):1919-1928. PubMed ID: 28762086 [TBL] [Abstract][Full Text] [Related]
38. Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy. Lee Y; Lee DK; Lee JM; Chung SJ; Lee JJ; Sohn YH; Lee PH Eur J Neurol; 2017 Jan; 24(1):212-218. PubMed ID: 27747983 [TBL] [Abstract][Full Text] [Related]